Universal Health Services, Inc. (UHS) expanding its growth trajectory ahead

With 1.05 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.56 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $157.18 whereas the lowest price it dropped to was $152.685. The 52-week range on UHS shows that it touched its highest point at $183.61 and its lowest point at $119.90 during that stretch. It currently has a 1-year price target of $187.33. With its current market cap of 10.33 billion, UHS has annualized dividend of $0.80 while the current yield stands at 0.52%. Beta for the stock currently stands at 1.28.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of UHS was down-trending over the past week, with a drop of -8.76%, but this was down by -14.75% over a month. Three-month performance dropped to -1.75% while six-month performance rose 20.67%. The stock gained 12.32% in the past year, while it has gained 0.79% so far this year. A look at the trailing 12-month EPS for UHS yields 10.25 with Next year EPS estimates of 14.84. For the next quarter, that number is 3.15. This implies an EPS growth rate of 25.18% for this year and 12.46% for next year. EPS is expected to grow by 19.22% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 4.26%.

Float and Shares Shorts:

At present, 59.93 million UHS shares are outstanding with a float of 57.41 million shares on hand for trading. On 2024-03-28, short shares totaled 1.46 million, which was 217.0 higher than short shares on 1709164800. In addition to Mr. Alan B. Miller as the firm’s Founder & Executive Chairman of the Board, Mr. Marc D. Miller serves as its CEO, President & Director.

Institutional Ownership:

Through their ownership of 0.98635 of UHS’s outstanding shares, institutional investors have minority control over the company.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2023-12-31, UHS reported revenue of $3703546000.0 and operating income of $331196000.0. The EBITDA in the recently reported quarter was $479049000.0 and diluted EPS was $nan.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for UHS since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.